BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 4301554)

  • 1. Influence of vasopressin and of a crude CRF preparation on pituitary ACTH-release in posterior-lobectomized rats.
    de Wied D
    Neuroendocrinology; 1968; 3(3):129-35. PubMed ID: 4301554
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased adrenal sensitivity to ACTH in the vasopressin-deficient (Brattleboro) rat.
    Wiley MK; Pearlmutter AF; Miller RE
    Neuroendocrinology; 1974; 14(5):257-70. PubMed ID: 4368017
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of a CRF preparation on ACTH release in rats bearing hypothalamic dexamethasone implants: a study on the "implantation paradox".
    Smelik PG
    Neuroendocrinology; 1969; 5(3):193-204. PubMed ID: 4312009
    [No Abstract]   [Full Text] [Related]  

  • 4. Release of ACTH by substances of central nervous system origin.
    de Wied D; Witter A; Versteeg DH; Mulder AH
    Endocrinology; 1969 Sep; 85(3):561-9. PubMed ID: 4307362
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site of corticotropin-releasing factor (CRF) releasing elements: effect of lesions on ACTH release and adenohypophysial blood flow.
    Porter JC
    Endocrinology; 1969 Jun; 84(6):1398-403. PubMed ID: 4305943
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasopressin and hypothalamo-pituitary-adrenocorticotrophic activity [proceedings].
    Buckingham JC; Leach JH
    J Physiol; 1979 Nov; 296():87P. PubMed ID: 231104
    [No Abstract]   [Full Text] [Related]  

  • 8. Potentiation by vasopressin of corticotropin release induced by corticotropin-releasing factor.
    Yates FE; Russell SM; Dallman MF; Hodge GA; McCann SM; Dhariwal AP
    Endocrinology; 1971 Jan; 88(1):3-15. PubMed ID: 4320769
    [No Abstract]   [Full Text] [Related]  

  • 9. Pituitary-adrenal relationships in mice with hereditary nephrogenic diabetes insipidus, with special emphasis on the neurohypophysis and pars intermedia.
    Naik DV
    Z Zellforsch Mikrosk Anat; 1970; 107(3):317-42. PubMed ID: 4317647
    [No Abstract]   [Full Text] [Related]  

  • 10. Pituitary-adrenal system in rats bearing lesions in the pituitary stalk.
    László FA; de Wied D
    Endocrinology; 1966 Sep; 79(3):547-53. PubMed ID: 4288525
    [No Abstract]   [Full Text] [Related]  

  • 11. Pituitary-adrenal function in the absence of vasopressin.
    McCann SM; Antunes-Rodrigues J; Nallar R; Valtin H
    Endocrinology; 1966 Dec; 79(6):1058-64. PubMed ID: 4288985
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulation of corticotropin release by corticotropin-releasing factor (CRF) or by vasopressin following intrapituitary infusions in unanesthetized dogs: inhibition of the responses by dexamethasone.
    Gonzalez-Luque A; L'age M; Dhariwal AP; Yates FE
    Endocrinology; 1970 May; 86(5):1134-42. PubMed ID: 4314067
    [No Abstract]   [Full Text] [Related]  

  • 13. Site of action of acute alcohol administration in stimulating the rat hypothalamic-pituitary-adrenal axis: comparison between the effect of systemic and intracerebroventricular injection of this drug on pituitary and hypothalamic responses.
    Lee S; Selvage D; Hansen K; Rivier C
    Endocrinology; 2004 Oct; 145(10):4470-9. PubMed ID: 15205375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by dexamethasone of the in vivo pituitary response to corticotropin-releasing factor (CRF).
    Russell SM; Dhariwal AP; McCann SM; Yates FE
    Endocrinology; 1969 Sep; 85(3):512-21. PubMed ID: 4307361
    [No Abstract]   [Full Text] [Related]  

  • 15. Neonatal facilitation of stress-induced adrenocorticotropin secretion by prior stress: evidence for increased central drive to the pituitary.
    Walker CD; Dallman MF
    Endocrinology; 1993 Mar; 132(3):1101-7. PubMed ID: 8382596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of assays for corticotrophin-releasing activity.
    Chan LT; de Wied D; Saffran M
    Endocrinology; 1969 Apr; 84(4):967-72. PubMed ID: 4304035
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative in vitro studies on corticotropin releasing activity of vasopressin and hypothalamic median eminence extract.
    Lutz-Bucher B; Koch B; Mialhe C
    Neuroendocrinology; 1977; 23(3):181-92. PubMed ID: 197442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of one-time stress on the reactivity of the hypophyseal-adrenal cortical system to corticotropin-releasing factor and vasopressin in rats].
    Podvigina TT
    Ross Fiziol Zh Im I M Sechenova; 1999 Mar; 85(3):462-5. PubMed ID: 10494599
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of selective surgical interruption of the anterior pituitary's blood supply on ACTH release.
    Porter JC; Mical RS; Tippit PR; Drane JW
    Endocrinology; 1970 Mar; 86(3):590-9. PubMed ID: 4312113
    [No Abstract]   [Full Text] [Related]  

  • 20. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
    Tizabi Y; Aguilera G
    Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.